Convergence Investment Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $231K | Buy |
+599
| New | +$222K | 0.02% | 229 |
|
|
2026
Q1 | – | Sell |
-635
| Closed | -$222K | – | 253 |
|
|
2025
Q4 | $222K | Buy |
635
+1
| +0.2% | +$338 | 0.04% | 238 |
|
|
2025
Q3 | $205K | Buy |
634
+59
| +10% | +$18.4K | 0.05% | 249 |
|
|
2025
Q2 | $224K | Sell |
575
-12
| -2% | -$4.83K | 0.06% | 225 |
|
|
2025
Q1 | $256K | Buy |
587
+10
| +2% | +$4.01K | 0.07% | 221 |
|
|
2024
Q4 | $213K | Sell |
577
-101
| -15% | -$42.3K | 0.05% | 237 |
|
|
2024
Q3 | $353K | Sell |
678
-9
| -1% | -$4.81K | 0.1% | 195 |
|
|
2024
Q2 | $372K | Sell |
687
-21
| -3% | -$11.1K | 0.11% | 195 |
|
|
2024
Q1 | $367K | Sell |
708
-3
| -0.4% | -$1.49K | 0.14% | 172 |
|
|
2023
Q4 | $335K | Sell |
711
-6
| -0.8% | -$2.77K | 0.18% | 122 |
|
|
2023
Q3 | $312K | Buy |
717
+17
| +2% | +$7.71K | 0.18% | 112 |
|
|
2023
Q2 | $311K | Sell |
700
-41
| -6% | -$18.9K | 0.18% | 121 |
|
|
2023
Q1 | $341K | Sell |
741
-4
| -0.5% | -$1.9K | 0.2% | 111 |
|
|
2022
Q4 | $382K | Sell |
745
-75
| -9% | -$38.1K | 0.23% | 106 |
|
|
2022
Q3 | $373K | Sell |
820
-151
| -16% | -$72.3K | 0.24% | 99 |
|
|
2022
Q2 | $469K | Buy |
971
+88
| +10% | +$43.5K | 0.28% | 94 |
|
|
2022
Q1 | $434K | Sell |
883
-7
| -0.8% | -$3.2K | 0.22% | 109 |
|
|
2021
Q4 | $413K | Sell |
890
-24
| -3% | -$10.1K | 0.21% | 111 |
|
|
2021
Q3 | $341K | Buy |
914
+56
| +7% | +$21.3K | 0.18% | 128 |
|
|
2021
Q2 | $328K | Sell |
858
-32
| -4% | -$12.2K | 0.14% | 155 |
|
|
2021
Q1 | $319K | Sell |
890
-10
| -1% | -$3.22K | 0.15% | 146 |
|
|
2020
Q4 | $289K | Buy |
900
+9
| +1% | +$2.76K | 0.15% | 142 |
|
|
2020
Q3 | $239K | Buy |
891
+5
| +0.6% | +$1.34K | 0.08% | 222 |
|
|
2020
Q2 | $233K | Buy |
+886
| New | +$236K | 0.08% | 203 |
|
|
2020
Q1 | – | Sell |
-898
| Closed | -$271K | – | 231 |
|
|
2019
Q4 | $271K | Sell |
898
-7
| -0.8% | -$1.93K | 0.08% | 201 |
|
|
2019
Q3 | $217K | Sell |
905
-38
| -4% | -$10.4K | 0.06% | 206 |
|
|
2019
Q2 | $266K | Buy |
943
+38
| +4% | +$10.4K | 0.06% | 210 |
|
|
2019
Q1 | $260K | Sell |
905
-22
| -2% | -$6.36K | 0.06% | 239 |
|
|
2018
Q4 | $243K | Buy |
927
+93
| +11% | +$25.6K | 0.06% | 282 |
|
|
2018
Q3 | $228K | Sell |
834
-73
| -8% | -$18.9K | 0.05% | 295 |
|
|
2018
Q2 | $216K | Buy |
907
+3
| +0.3% | +$695 | 0.03% | 290 |
|
|
2018
Q1 | $199K | Buy |
+904
| New | +$212K | 0.03% | 286 |
|
|
2017
Q3 | – | Sell |
-2,999
| Closed | -$564K | – | 346 |
|
|
2017
Q2 | $564K | Buy |
+2,999
| New | +$539K | 0.08% | 285 |
|
|
2016
Q3 | – | Sell |
-22,173
| Closed | -$2.91M | – | 346 |
|
|
2016
Q2 | $2.91M | Sell |
22,173
-5,254
| -19% | -$719K | 0.4% | 85 |
|
|
2016
Q1 | $3.81M | Buy |
+27,427
| New | +$3.67M | 0.45% | 81 |
|
|
2015
Q4 | – | Sell |
-8,613
| Closed | -$1.21M | – | 344 |
|
|
2015
Q3 | $1.21M | Sell |
8,613
-15,830
| -65% | -$2.38M | 0.14% | 231 |
|
|
2015
Q2 | $4.01M | Buy |
24,443
+23,060
| +1,667% | +$3.68M | 0.4% | 88 |
|
|
2015
Q1 | $214K | Buy |
+1,383
| New | +$197K | 0.03% | 345 |
|
|
2013
Q4 | – | Sell |
-24,772
| Closed | -$2.07M | – | 387 |
|
|
2013
Q3 | $2.07M | Buy |
24,772
+2,946
| +13% | +$252K | 0.44% | 82 |
|
|
2013
Q2 | $1.79M | Buy |
+21,826
| New | +$1.63M | 0.46% | 69 |
|
Other funds holding ELV
Convergence Investment Partners's ELV Position: Q2 2026 in Review
Convergence Investment Partners opened a new position in Elevance Health (ELV) in Q2 2026: 599 shares worth $231K. The stake represents 0.02% of the portfolio and ranks #229 among its holdings. This is a return to the name: Convergence Investment Partners previously reported a position in ELV as recently as Q4 2025.
Convergence Investment Partners first reported a position in ELV in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.01M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Convergence Investment Partners held 599 shares of Elevance Health worth $231K as of Q2 2026.
- Elevance Health was a new Convergence Investment Partners position in Q2 2026.
- Elevance Health made up 0.02% of Convergence Investment Partners's portfolio in Q2 2026, its #229 holding.
- Convergence Investment Partners first reported a position in Elevance Health in Q2 2013 and has held it in 40 quarters since.
- Convergence Investment Partners's Elevance Health position peaked at $4.01M in Q2 2015.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.